158 related articles for article (PubMed ID: 23795348)
1. Reduced Expression of RNA Binding Protein CELF2, a Putative Tumor Suppressor Gene in Colon Cancer.
Ramalingam S; Ramamoorthy P; Subramaniam D; Anant S
Immunogastroenterology; 2012; 1(1):27-33. PubMed ID: 23795348
[TBL] [Abstract][Full Text] [Related]
2. Pleotropic role of RNA binding protein CELF2 in autophagy induction.
New J; Subramaniam D; Ramalingam S; Enders J; Sayed AAA; Ponnurangam S; Standing D; Ramamoorthy P; O'Neil M; Dixon DA; Saha S; Umar S; Gunewardena S; Jensen RA; Thomas SM; Anant S
Mol Carcinog; 2019 Aug; 58(8):1400-1409. PubMed ID: 31020708
[TBL] [Abstract][Full Text] [Related]
3. RNA-binding protein CELF2 inhibits breast cancer cell invasion and angiogenesis by downregulating NFATc1.
Zhou L; Xie X
Exp Ther Med; 2021 Aug; 22(2):898. PubMed ID: 34257711
[TBL] [Abstract][Full Text] [Related]
4. The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B.
Guo Q; Wu Y; Guo X; Cao L; Xu F; Zhao H; Zhu J; Wen H; Ju X; Wu X
Mol Ther Nucleic Acids; 2021 Mar; 23():169-184. PubMed ID: 33335801
[TBL] [Abstract][Full Text] [Related]
5. Induced transcription and stability of CELF2 mRNA drives widespread alternative splicing during T-cell signaling.
Mallory MJ; Allon SJ; Qiu J; Gazzara MR; Tapescu I; Martinez NM; Fu XD; Lynch KW
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):E2139-48. PubMed ID: 25870297
[TBL] [Abstract][Full Text] [Related]
6. Diversity and conservation of CELF1 and CELF2 RNA and protein expression patterns during embryonic development.
Blech-Hermoni Y; Stillwagon SJ; Ladd AN
Dev Dyn; 2013 Jun; 242(6):767-77. PubMed ID: 23468433
[TBL] [Abstract][Full Text] [Related]
7. RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cells.
Subramaniam D; Ramalingam S; Linehan DC; Dieckgraefe BK; Postier RG; Houchen CW; Jensen RA; Anant S
PLoS One; 2011 Feb; 6(2):e16958. PubMed ID: 21347286
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-SNHG16 promotes proliferation and migration of acute myeloid leukemia cells via PTEN/PI3K/AKT axis through suppressing CELF2 protein.
Shi M; Yang R; Lin J; Wei QI; Chen L; Gong W; Li Y; Guo X
J Biosci; 2021; 46():. PubMed ID: 33576342
[TBL] [Abstract][Full Text] [Related]
10. Loss of CELF2 promotes skin tumorigenesis and increases drug resistance.
Sah B; Singh J; Shen Y; Goldfarb N; Samie FH; Geskin LJ; Liu L
Int J Dermatol; 2024 Jun; ():. PubMed ID: 38887832
[TBL] [Abstract][Full Text] [Related]
11. CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3.
Turchi L; Sakakini N; Saviane G; Polo B; Saurty-Seerunghen MS; Gabut M; Gouillou CA; Guerlais V; Pasquier C; Vignais ML; Almairac F; Chneiweiss H; Junier MP; Burel-Vandenbos F; Virolle T
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894405
[TBL] [Abstract][Full Text] [Related]
12. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-20a Regulates Glioma Cell Proliferation, Invasion, and Apoptosis by Targeting CUGBP Elav-Like Family Member 2.
Liao C; Chen W; Wang J
World Neurosurg; 2019 Jan; 121():e519-e527. PubMed ID: 30268547
[TBL] [Abstract][Full Text] [Related]
14. miR-615-3p promotes proliferation and migration and inhibits apoptosis through its potential target CELF2 in gastric cancer.
Wang J; Liu L; Sun Y; Xue Y; Qu J; Pan S; Li H; Qu H; Wang J; Zhang J
Biomed Pharmacother; 2018 May; 101():406-413. PubMed ID: 29501762
[TBL] [Abstract][Full Text] [Related]
15. Position-dependent activity of CELF2 in the regulation of splicing and implications for signal-responsive regulation in T cells.
Ajith S; Gazzara MR; Cole BS; Shankarling G; Martinez NM; Mallory MJ; Lynch KW
RNA Biol; 2016 Jun; 13(6):569-81. PubMed ID: 27096301
[TBL] [Abstract][Full Text] [Related]
16. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine-mediated CELF2 regulates CD44 alternative splicing affecting tumorigenesis via ERAD pathway in pancreatic cancer.
Lai S; Wang Y; Li T; Dong Y; Lin Y; Wang L; Weng S; Zhang X; Lin C
Cell Biosci; 2022 Aug; 12(1):125. PubMed ID: 35941702
[TBL] [Abstract][Full Text] [Related]
18. Triclosan regulates alternative splicing events of nerve-related genes through RNA-binding protein CELF2 to induce zebrafish neurotoxicity.
Wang D; Wang X; Huang H; Wang H
J Hazard Mater; 2021 Jul; 413():125414. PubMed ID: 33621777
[TBL] [Abstract][Full Text] [Related]
19. RNA Binding Protein CELF2 Regulates Signal-Induced Alternative Polyadenylation by Competing with Enhancers of the Polyadenylation Machinery.
Chatrikhi R; Mallory MJ; Gazzara MR; Agosto LM; Zhu WS; Litterman AJ; Ansel KM; Lynch KW
Cell Rep; 2019 Sep; 28(11):2795-2806.e3. PubMed ID: 31509743
[TBL] [Abstract][Full Text] [Related]
20. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
